# US 2025/0083146 A1 · Nucleic acid testing in a portable device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0083146 A1
- Document ID: US20250083146A1
- Status: Published application
- Kind: A1
- Application number: 18/847,871
- Filed: 2023-03-21
- Published: 2025-03-13
- Earliest claimed: 2022-03-22
- Assignees: The Penn State Research Foundation
- Applicants: The Penn State Research Foundation
- Inventors: Weihua Guan; Tianyi Liu; Anthony J. Politza
- Web page: https://patentgrep.com/patent/US20250083146A1

## CPC

- B01L 3/502761: {specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules}
- G01N 35/0098: {involving analyte bound to insoluble magnetic carrier, e.g. using magnetic separation (magnetic particles used in immunoassays G01N33/54326; magnetic separation in general B03C)}
- B01L 3/502715: {characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces}
- B01L 7/525: {with physical movement of samples between temperature zones}
- B03C 1/288: {disposed at the outer circumference of a recipient}
- C12N 15/1013: {by using magnetic beads}
- B01L 2200/0673: Handling of plugs of fluid surrounded by immiscible fluid
- B01L 2200/0684: Venting, avoiding backpressure, avoid gas bubbles
- B01L 2200/14: Process control and prevention of errors
- B01L 2200/16: Reagents, handling or storing thereof
- B01L 2300/1827: using resistive heater
- B01L 2400/043: magnetic forces
- B03C 2201/18: Magnetic separation whereby the particles are suspended in a liquid
- B03C 2201/26: for use in medical or biological applications
- C12Q 1/701: {Specific hybridization probes}
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B03C: MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS (separating isotopes B01D59/00; combinations of magnetic or electrostatic separation with separation of solids by other means B03B, B07B)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

A nucleic acid testing device includes a microfluidic cartridge, an analyzer and a processing unit for controlling the analyzer. The microfluidic cartridge includes a binding chamber, a washing chamber and a reaction chamber. The analyzer includes a mechanical module including an electromagnetic coil array and a permanent magnet. The electromagnetic coil array is programmed to generate a programmable pulsed electromagnetic field to actuate the permanent magnet that further controls a paramagnetic bead (PMB) assay in the cartridge to move among the adjacent chambers.

## Claims

### Claim 1

A nucleic acid testing device, comprising:
a microfluidic cartridge having a binding chamber, a washing chamber and a reaction chamber;
an analyzer having a mechanical module, the mechanical module including an electromagnetic coil array and a permanent magnet, the electromagnetic coil array generating a programmable pulsed electromagnetic field to actuate the permanent magnet that further controls a paramagnetic bead (PMB) assay in the cartridge; and
a processing unit for controlling the analyzer.

### Claim 2 (depends on 1)

The nucleic acid testing device according to claim 1, wherein the electromagnetic coil array is a double-sized planar electromagnetic coil array.

### Claim 3 (depends on 1)

The nucleic acid testing device according to claim 1, wherein the electromagnetic coil array is a linear array.

### Claim 4 (depends on 1)

The nucleic acid testing device according to claim 1, wherein the electromagnetic coil array is a 2D array organized in blocks and groups.

### Claim 5 (depends on 4)

The nucleic acid testing device according to claim 4, wherein each block holds three groups, each group having a group designation, coils with a same group designation are interconnected across blocks.

### Claim 6 (depends on 1)

The nucleic acid testing device according to claim 1, wherein the electromagnetic coil array and the permanent magnet are located above or under the microfluidic cartridge.

### Claim 7 (depends on 1)

The nucleic acid testing device according to claim 1, wherein the microfluidic cartridge further comprises valve chambers located between the binding chamber, the washing chamber and the reaction chamber.

### Claim 8 (depends on 1)

The nucleic acid testing device according to claim 1, wherein the microfluidic cartridge further comprises air traps and inlet ports.

### Claim 9 (depends on 1)

The nucleic acid testing device according to claim 1, wherein the analyzer further comprises an optical module for excitation/detection and a thermal module for actuation/sensing.

### Claim 10 (depends on 1)

The nucleic acid testing device according to claim 1, further comprising a battery for powering the nucleic acid testing device.

### Claim 11 (depends on 1)

The nucleic acid testing device according to claim 1, further comprising a housing in which the cartridge and analyzer are disposed.

### Claim 12

A method of nucleic acid testing, comprising the steps of:
providing a nucleic acid testing device, comprising:
a microfluidic cartridge having a binding chamber, a washing chamber and a reaction chamber;
an analyzer having an electromagnetic coil array paired with a permanent magnet;
providing a paramagnetic bead (PMB) assay bound to nucleic acids forming nucleic acid-bead complexes;
driving the nucleic acid-bead complexes into the washing chamber using the permanent magnet;
removing unwanted proteins and salts carried along with the nucleic acids in the washing chamber;
moving the nucleic acid-bead complexes into the reaction chamber using the permanent magnet for elution where the nucleic acids dissociate from the PMBs; and
moving the PMBs away from the reaction chamber using the permanent magnet, leaving the nucleic acids in the reaction chamber for downstream analysis.

### Claim 13 (depends on 12)

The method according to claim 12, further comprising programming the electromagnetic coil array to generate a localized pulsed electromagnetic field to control the permanent magnet.

### Claim 14 (depends on 12)

The method according to claim 12, wherein the electromagnetic coil array is a linear double-sized planar electromagnetic coil array.

### Claim 15 (depends on 12)

The method according to claim 12, wherein the electromagnetic coil array is a 2D array organized in blocks and groups and activated in series.

### Claim 16 (depends on 15)

The method of claim 15, wherein each block holds three groups, each group having a group designation, coils with a same group designation are interconnected across blocks, coils are activated by group designation.

### Claim 17 (depends on 12)

The method according to claim 12, wherein beads in the assay are horizontally agitated by a programmed electromagnetic sequence.

### Claim 18 (depends on 12)

The method according to claim 12, wherein the nucleic acid is HIV, HPV, HBV, HCV RNAs.

### Claim 19 (depends on 12)

The method according to claim 12, wherein the nucleic acid is a DNA.

### Claim 20 (depends on 12)

The method according to claim 12, wherein the sample is blood, plasma, urine, saliva, or virus transfer medium.
